文献速递遗传性与小管间质肾病

原发性高草酸尿症3型的临床特征:与1型和2型的比较

Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

基于罕见肾结石联盟PH注册队列(PH1=384,PH2=51,PH3=62),本研究比较了PH3与PH1、PH2的临床表现。PH3患者症状出现中位年龄2.7岁,诊断时7%有肾钙质沉着、89%有结石;尿草酸排泄最低而尿钙最高;40岁时97%的PH3患者未进展至终末期肾病,而PH1为36%、PH2为66%。

要点

  • PH3症状出现早(中位2.7岁),以结石为主,肾钙质沉着少见。
  • PH3尿草酸排泄显著低于PH1和PH2,尿钙显著高于两者。
  • PH3进展至终末期肾病罕见,40岁时97%未进展。

核心结论

  • 所有类型的PH患者终生均有结石事件,常始于儿童期;肾衰竭在PH1常见但在PH3罕见。

研究设计与样本

  • 研究基于罕见肾结石联盟PH注册队列,纳入PH1患者384例、PH2患者51例、PH3患者62例,获取临床信息进行比较。

主要发现

  • PH3患者症状出现中位年龄2.7岁,PH1为4.9岁,PH2为5.7岁(P=0.14)。
  • 诊断时PH3患者中肾钙质沉着4例(7%),结石55例(89%)。
  • 中位尿草酸排泄PH3为1.1 mmol/day/1.73 m2,PH1为1.6、PH2为1.5(P<0.001);尿钙PH3为112 mg/day/1.73 m2,PH1为51、PH2为98(P<0.001)。
  • 每十年结石事件数在各年龄段及三种PH类型间相似。
  • 40岁时97%的PH3患者未进展至终末期肾病,而PH1为36%、PH2为66%。

临床怎么用

  • 对早发结石患儿应警惕PH3可能,尽管其肾钙质沉着少见且尿草酸排泄较低。
  • PH3患者需长期随访结石事件,但进展至终末期肾病风险较低。

局限性

  • 需要更大队列的长期随访以更全面理解PH3表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary hyperoxaluria (PH) type 3 (PH3) is caused by mutations in the hydroxy-oxo-glutarate aldolase 1 gene. PH3 patients often present with recurrent urinary stone disease in the first decade of life, but prior reports suggested PH3 may have a milder phenotype in adults. This study characterized clinical manifestations of PH3 across the decades of life in comparison with PH1 and PH2. METHODS: Clinical information was obtained from the Rare Kidney Stone Consortium PH Registry (PH1, n = 384; PH2, n = 51; PH3, n = 62). RESULTS: PH3 patients presented with symptoms at a median of 2.7 years old compared with PH1 (4.9 years) and PH2 (5.7 years) (P = 0.14). Nephrocalcinosis was present at diagnosis in 4 (7%) PH3 patients, while 55 (89%) had stones. Median urine oxalate excretion was lowest in PH3 patients compared with PH1 and PH2 (1.1 versus 1.6 and 1.5 mmol/day/1.73 m2, respectively, P < 0.001) while urine calcium was highest in PH3 (112 versus 51 and 98 mg/day/1.73 m2 in PH1 and PH2, respectively, P < 0.001). Stone events per decade of life were similar across the age span and the three PH types. At 40 years of age, 97% of PH3 patients had not progressed to end-stage kidney disease compared with 36% PH1 and 66% PH2 patients. CONCLUSIONS: Patients with all forms of PH experience lifelong stone events, often beginning in childhood. Kidney failure is common in PH1 but rare in PH3. Longer-term follow-up of larger cohorts will be important for a more complete understanding of the PH3 phenotype.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Singh P, Viehman JK, Mehta RA, et al. Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2. Nephrol Dial Transplant. 2022. PMID: 33543760. doi:10.1093/ndt/gfab027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。